Pharmacoeconomics Flashcards
Types of economic outcomes (cost)
Cost is value of resources consumed by a program/drug therapy of interest
Direct- medical or non-medical (transport or medications)
Indirect- lost wages
Time- lost due to illness or treatment
Intangible costs - pain or suffering
Types of economic outcomes (consequences)
Consequence is defined as effects, outputs, or outcomes of drug therapy
QALY- quality adjusted life years. 0= death, 1= perfect health.
QALY= number of life years remaining x QOL
Types of analysis
Explain COI
Cost identification / minimisation
Cost effectiveness
Cost benefit
Cost utility
Net monetary benefit
Cost of illness (COI) - identifies and estimates overall cost of a disease for a population
Measures direct and indirect cost
Not used to compare competing treatment alternatives, but to provide estimate of financial burden
Explain CMA
Cost minimisation analysis
Determines of least costly alternative when comparing 2+ treatments
Not difference in outcomes
Alternatives must have equivalent safety and efficacy
Measured in dollars
Explain CEA
Cost effectiveness analysis
Estimates differences in costs and differences in outcomes between interventions
E.g. PPI vs H2Rantag in PUD
Cost- dollars
Outcomes- lives saved, life expectancy, bp drop)
Explain CUA
Cost utility analysis
Compares different treatments from different pharmacological classes for management of different diseases
Quality adjusted life years used
Best treatment= lowest cost per QALY
Explain CBA
Cost benefit analysis
Estimates differences in cost and benefits in same units (money)
Compare two different programs
Expressed as a ratio (benefit-cost), a net benefit, or net cost.
Economic study perspectives
Patient perspective- what patient pays
Provider perspective- expense of providing a product or service (hospitals, private-practise physicians)
Payer perspective- insurance companies, employers, or government
Societal - broad
Steps in economic evaluation
Step 1- quantify costs of care
Step 2- quantify outcomes
Step 3- assess average costs and outcomes, if they differ among treatment groups
Step 4- compare differences in costs and outcomes and evaluate value of costs
Step 5- perform sensitivity analysis
Critical appraisal of economic literature or evidence
Assess technical merit of study, are results applicable to local decision making, do results apply generally in different jurisdictions w/ different perspectives?